Sana Biotechnology R&D President Douglas Williams resigns effective April 18, 2024

Sana Biotechnology, Inc.

Douglas Williams, Ph.D., resigned as EVP and President, Research and Development.
Resignation effective April 18, 2024; voluntary for personal reasons.
No disagreement with the company cited; no successor named.
Williams' departure removes a key R&D leader in a biotech with no pipeline-stage products.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Douglas Williams

Executive Vice President and President, Research and Development

SANA · Sana Biotechnology, Inc.

Effective: 2024-04-18
Filed: April 18, 2024, 7:59 PM ET

Effective April 18, 2024, Douglas Williams, Ph.D. resigned from his position as Executive Vice President and President, Research and Development of Sana Biotechnology, Inc. (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Douglas Williams resigned as Executive Vice President and President, Research and Development at Sana Biotechnology, Inc..

Action: resigned
Role: Executive Vice President and President, Research and Development

Exact text from the filing

Effective April 18, 2024, Douglas Williams, Ph.D. resigned from his position as Executive Vice President and President, Research and Development of Sana Biotechnology, Inc. (the “Company”).

View on SEC.gov

Sana Biotechnology, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-100902

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.